Ascariasis remains the most common helminth infection in humans. As an alternative or complementary approach to global deworming， a pan-anthelminthic vaccine is under development targeting Ascaris， hookworm， and Trichuris infections. As16 and As14 have previously been described as two genetically related proteins from Ascaris suum that induced protective immunity in mice when formulated with cholera toxin B subunit (CTB) as an adjuvant， but the exact protective mechanism was not well understood.
Ascariasis remains the most common helminth infection in humans. As an alternative or complementary approach to global deworming， a pan-anthelminthic vaccine is under development targeting Ascaris， hookworm， and Trichuris infections. As16 and As14 have previously been described as two genetically related proteins from Ascaris suum that induced protective immunity in mice when formulated with cholera toxin B subunit (CTB) as an adjuvant， but the exact protective mechanism was not well understood.
